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Abstract
Background: Population aging is closely related to high prevalence of chronic conditions in developed countries. In this
context, health care policies aim to increase life span cost-effectively while maintaining quality of life and functional ability.
There is still, however, a need for further understanding of how chronic conditions affect these health aspects. The aim of
this paper is to assess the individual and combined impact of chronic physical and mental conditions on quality of life and
disability in Spain, and secondly to show gender trends.
Methods: Cross-sectional data were collected from the COURAGE study. A total of 3,625 participants over 50 years old from
Spain were included. Crude and adjusted multiple linear regressions were conducted to detect associations between
individual chronic conditions and disability, and between chronic conditions and quality of life. Separate models were used
to assess the influence of the number of diseases on the same variables. Additional analogous regressions were performed
for males and females.
Results: All chronic conditions except hypertension were statistically associated with poor results in quality of life and
disability. Depression, anxiety and stroke were found to have the greatest impact on outcomes. The number of chronic
conditions was associated with substantially lower quality of life [b for 4+ diseases: 218.10 (220.95,215.25)] and greater
disability [b for 4+ diseases: 27.64 (24.99,30.29]. In general, women suffered from higher rates of multimorbidity and poorer
results in quality of life and disability.
Conclusions: Chronic conditions impact greatly on quality of life and disability in the older Spanish population, especially
when co-occurring diseases are added. Multimorbidity considerations should be a priority in the development of future
health policies focused on quality of life and disability. Further studies would benefit from an expanded selection of
diseases. Policies should also deal with gender idiosyncrasy in certain cases.
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Background
Population aging has gradually increased over the last years,
with projections suggesting a two-fold increase in the worldwide
population over 60 years old between 2013 and 2050 [1]. By then,
the proportion of older people is expected to be double that of
children in developed countries [2]. This demographic trend has
led the European Commission to identify population aging as a
crucial challenge in the 21st century [3].
PLOS ONE | www.plosone.org 1 November 2014 | Volume 9 | Issue 11 | e111498
The aging process is associated with the onset of chronic
conditions so that two thirds of elderly citizens in Europe suffer
from multimorbidity, defined as the presence of at least two co-
occurring conditions [4,5]. Poor clinical and financial outcomes
have been observed in patients with multimorbidity [6]. Chronic,
non-communicable diseases are the biggest cause of death in high-
income countries; responsible for more than 70% of deaths in
2008 [7]. Costs associated with chronic conditions have been
estimated at 75% of total health expenditure, which is related to a
wide range of health services such as hospitalization, medication,
physician consultation, transportation, rehabilitation or long-term
care [8,9]. Health care in this context should aim to increase life
span in a cost-efficient way while maintaining quality of life and
the abilities required to perform daily-life activities [10].
Disability and quality of life are health outcomes which reflect
the global health of the individual at various levels [11–14].
Disability is an umbrella term that reflects problems in bodily
function, task performance and participation in life situations [12].
Quality of life is a broad multidimensional concept that includes
both positive and negative aspects of life, and constitutes a major
issue in the elderly [13,14]. When analyzing the impact of chronic
conditions on disability and quality of life, most studies have
focused on the study of a single condition [15]. Lower quality of
life and higher rates of disability have been found in people with
chronic diseases such as arthritis, diabetes or asthma whilst limited
or controversial results have been found for other conditions [16–
21]. In other cases, the effect of chronic conditions on quality of
life or disability has been assessed by using an index condition as a
reference and the effects when considering the combination with
other conditions [22–24]. This implies, for example, assessing how
a specific index disease, such as diabetes, interacts with other
conditions, e.g., diabetes and hypertension, diabetes and asthma.
Comorbidity, or the study of these specific pairs of conditions, was
introduced by Feinstein and adds very valuable information but
also has its limitations [25]. Using this approach, an additive,
synergistic or subtractive effect of these pair combinations can be
explored. However, by using comorbidity pairs, neither the
majority of all possible combinations nor the cumulative effects
are studied, so that another, more comprehensive approach
including the most relevant combinations is needed.
Multimorbidity is a relatively new concept that considers the co-
occurrence of diseases in individual patients. This concept goes
beyond the comorbidity definition, is not based on a central
disease, and allows the assessment of the cumulative effect of
chronic conditions [5]. Some recent studies have introduced
comprehensive analyses including pairs, organ domains, or
cumulative effects but there is still a need to deepen understanding
of the additive impact of chronic conditions on disability and
quality of life [26–29]. For example, McDaid et al (2013) recently
presented a study assessing the effect of multiple chronic
conditions on disability and quality of life in which the importance
of co-occurring conditions was considered. One of its limitations
was the classification of diseases into 4 groups (cardiovascular
diseases, lung diseases, chronic pain, diabetes), so that the real
impact of each condition was not assessed independently. Despite
this limitation, it is one of the few papers assessing the effect of the
number of chronic conditions on disability and quality of life [26].
Griffith et al (2010) also showed interesting results regarding
chronic conditions taking multimorbidity into account. However,
they opted to add pairs or triads of chronic conditions to the model
rather than the number of chronic conditions [29].
Over recent years, the need to provide guidelines that consider
the impact of co-occurring chronic conditions has been highlight-
ed [25]. Thus, evaluation of the impact of multiple chronic
conditions on quality of life and disability is essential as a first step
to guide research and adjust guidelines, especially in Spain, where
very little information is available [30,31]. The importance of
detecting the leading preventable causes of negative health
outcomes, such as disability, is central to facilitating responses at
a public health level. Thus, quantifying the chronic disease burden
is essential [32]. Moreover, variability in methodology in previous
studies underlines the need to provide results using standardized
tools that allow cross-national comparisons in the future.
Furthermore, gender differences are known to exist with respect
to disability, quality of life and chronic diseases but very little is
known about the relationship between them [18,33,34]. Finally,
since most of the studies referring to index conditions have been
carried out in a clinical setting, a more comprehensive public
health perspective is needed focusing especially on the elderly, the
age group most frequently affected by multimorbidity.
Understanding the factors that interact with disability and
quality of life is essential to find ways of assessing, preventing and
dealing with these issues at a public health level. This paper aims
to assess the individual, combined and cumulative impact of
chronic physical and mental conditions on quality of life and
disability in a representative sample of older adults in the Spanish
general population. Secondly, the paper aims to provide evidence
on these issues across gender.
Methods
Design
The COURAGE in Europe project is a cross-sectional
household survey conducted on a representative sample of the
non-institutionalized adult population in Finland, Poland and
Spain [35]. Data from the Spanish sample is analyzed in the
current paper.
Sample and procedures
A national representative sample of the Spanish adult popula-
tion was selected by a stratified multistage clustered area
probability method. A community-residing population over 18
years old was the target group. Three samples were chosen
according to age: 18–49 years; 50–79 years; $80 years. Subgroups
50+ and 80+ years were oversampled, since these were the main
target of the study. Exclusion criteria consisted of: lack of fluency
in Spanish, house vacant/occupants elsewhere, deceased infor-
mant, individual not accessible [institutionalized/incarcerated/
hospitalized), and the mentally unfit. Eligibility criteria were not
met for 2,649 adults, with ‘‘occupants elsewhere/vacant house’’
the most common cause (74%). The survey protocol was translated
from English into Spanish following WHO translation guidelines
for assessment instruments [36]. Lay interviewers were trained on
the survey before its administration. Quality assurance strategies
were implemented during fieldwork [37]. The final response rate
was 69.9%, corresponding to 4,583 adults over 18 years old. The
response rate took into account the following issues: completed
interview, partial interview, final refusal, inability to locate
household or individual respondent, unsafe or dangerous area
preventing the access to the interviewee and completed interviews
not approved because of quality control problems. Of these, final
refusal was the main cause of exclusion (80% of the overall
excluded). Face-to-face structured interviews were conducted
through Computer-Assisted Personal Interviewing (CAPI) at
respondents’ homes between July, 2011 and May, 2012. The
interviewer judged whether the interviewee had cognitive prob-
lems at the beginning of the interview. This was a subjective
judgment, which was indicated in case of clear memory problems
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or severe mental disorders. If unsure, the interviewer could ask two
questions to help with the decision: ‘‘a) How would you best
describe your memory at present? Is it very good, good, moderate,
bad or very bad? b) Compared to 12 months ago, would you say
your memory is now better, the same or worse than it was then?’’. At
this stage, respondents who answer ‘‘bad’’ or ‘‘very bad’’ to the
first question and/or ‘‘worse’’ to the second question were used to
consider the respondent had memory problems. Moreover, all
proxy interviewees were evaluated by a supervisor to confirm this
decision. In this case, a short version of the survey was
administered to a proxy respondent. Data from proxy respondents
was not analyzed because diagnosis of physical conditions and
mental disorders was not performed in the proxy interviews. Thus,
the final analysis consisted of 3,625 participants over 50 years old,
once the 166 proxy respondents and the 792 participants younger
than 50 years old had been removed.
Data collection
Sociodemographic information included gender, age, marital
status, education level, employment status and urbanicity. With
regard to chronic physical conditions, participants were asked
about having received a life-time diagnosis and treatment within
the previous 12 months for angina, arthritis, asthma, chronic
obstructive pulmonary disease (COPD), diabetes, edentulism,
hypertension and stroke. Treatment was assessed with the
following question: ‘‘Did you receive medication or other
treatment for this disease during the last 12 months?’’. Addition-
ally, validated algorithms based on clinical symptoms were
implemented to detect undiagnosed cases [38]. These algorithms
come originally from the WHO’s SAGE study and are in line with
current clinical guidelines and reference publications [38–46].
When at least one of the two previous criteria was met, the
respondent was considered to have one of the following conditions:
arthritis, asthma, angina, stroke or chronic lung disease. Current
cataract was assessed through self-reported medical diagnosis with
co-occurring symptoms of cataract (visual problems associated
with light sources and symptoms of blurred vision) to prevent the
inclusion of respondents that had received corrective surgery. The
symptoms were assessed, as in the WHO’s SAGE study
questionnaire, with the following questions: ‘‘In the last 12 months
have you experienced any of the following: a)… cloudy or blurry
vision? b)… vision problems with light, such as glare from bright
lights, or halos around lights?’’ Hypertension, diabetes and
edentulism did not have symptomatic algorithms since they are
mostly asymptomatic conditions. Previous 12-months depression
and anxiety were assessed with an adapted version of the World
Health Organization Composite International Diagnostic Inter-
view (CIDI), according to DSM-IV criteria [47]. For the
assessment of functioning and disability we used the 12-item,
validated version of the World Health Organization Disability
Assessment Schedule 2.0 (WHODAS 2.0) [48]. Results range from
0 (no disability) to 100 (maximum disability). Quality of life was
assessed through a modified version of the World Health
Organization Quality of Life instrument (WHOQOL) called
WHOQOL-AGE that has been specially adapted for the elderly
population. This short-version contains 13 out of 100 questions
from the original version and has been validated in populations
over 50 years old [49]. Results range from 0 (minimum quality of
life) to 100 (maximum quality of life).
Statistical analysis
Unweighted frequencies, weighted proportions, means, confi-
dence intervals and cross tabulations were applied for descriptive
analysis. The Chi-square test was used to measure differences in
prevalence of chronic diseases, number of conditions and socio-
demographic variables across gender. T-test was used to assess
differences in age, quality of life and disability across gender. T-test
was also applied to evaluate differences in disability and quality of
life for chronic conditions across gender.
To assess which pairs of conditions should be included in the
analysis we took into account all 55 possible combinations from
our 11 conditions. Frequency of disease pairs was computed. For
those combinations with a co-occurrence higher than 1%, we
calculated the multimorbidity coefficient as follows: real preva-
lence of the combination divided by the expected prevalence
(expected prevalence = prevalence disease A x prevalence disease
B) [50,51]. We then selected the 10 pairs with the highest
coefficient score, obtaining a list with the most prevalent and
comorbid pairs in our population. The use of the multimorbidity
index to further restrict our selection was made according to recent
evidence in the study of comorbidity and multimorbidity that
highlights the underlying structure (shared risk factors risks and
biological links) present in some of these associations, which have
great interest at several levels (understanding of ethiopathology,
disease prevention, disease management, healthcare costs) [46,52].
We fitted a linear regression model for every combination to test
whether interactions were present with regard to the dependent
variable: quality of life and disability. Those pairs with p value ,
0.2 were considered to interact and were selected for ulterior
analysis.
Adjusted multiple linear regression was used to examine the
association between physical conditions and quality of life in
participants over 50 years old (n = 3,625). The model was adjusted
for age, gender, educational level, marital status, urbanicity, all
chronic conditions and those interactions with p,0.2: asthma with
chronic obstructive lung disease (asthmaxCOPD); cataract with
diabetes (cataractxdiabetes). This model was replicated using the
number of chronic conditions rather than the individual variables
to assess the additive effect in quality of life. Analogous procedures
were applied to assess the association between chronic conditions
and disability, considering the significant interactions for this
outcome: depression with anxiety (depressionxanxiety) and cata-
ract with diabetes (cataractxdiabetes).
Analogously, separate regressions were carried out for males
and females to assess trends according to gender, as shown in the
tables. To clarify the interpretation of these separate regressions by
gender, additional statistical tests were performed: interactions
between each chronic condition variable and gender were
computed. Interactions were found in depression with respect to
quality of life; and in diabetes, co-occurring cataract-diabetes, and
the number of chronic conditions with respect to disability. The
distinct impacts by gender have to be considered when interpret-
ing the results of these diseases across gender.
Although beta-coefficients in the regressions can be considered a
measure of effect size, we also computed the squared eta values
with the aim of clarifying the meaning of our results. Squared eta is
interpreted as the proportion of variance in the outcome explained
by the variance in the independent variable. General recommen-
dations for interpretation of squared eta results for ANOVA and
GLM were followed: 0.01 small; 0.06 medium; 0.14 large.
Depression, arthritis and the number of chronic conditions were
considered to have large effect on outcomes. The other chronic
condition variables produced moderate or small/moderate effect
size values. Gender was considered to have moderate/small size
effect.
The statistical analyses considered the complex nature of the
sample design. Weights were used in analyses to adjust for
differential probabilities of selection within households, and post-
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stratification weights to match the samples to socio-demographic
distributions. Analyses were performed with IBM SPSS statistics
19.
Ethics statement
The COURAGE study was approved by the Ethics Review
Committee at Fundacio´ Sant Joan de De´u, Barcelona, Spain and
the Ethics Review Committee, La Princesa University Hospital,
Madrid, Spain. Written informed consent was obtained from all
participants. All investigators worked according to the principles
expressed in the Declaration of Helsinki.
Results
Characteristics of participants
The study population consisted of 3,625 participants. A
summary of sociodemographic data, chronic condition prevalence,
disability results and quality of life score can be seen in Table 1.
Prevalence of chronic conditions differs across gender except for
hypertension, diabetes, asthma, stroke, edentulism and two of the
co-occurring combinations assessed: asthma-COPD and cataract-
diabetes. Women had higher rates of arthritis, depression, anxiety,
cataracts and the combination depression-anxiety while men had
higher prevalence of angina and COPD. 67.9% of the sample had
at least one chronic condition. Gender differences were found with
regard to the number of chronic conditions, with women having a
greater number of chronic conditions (p,0.001). Women also had
poorer results in quality of life and disability than men.
Impact of chronic conditions on quality of life and
disability
A summary of the scores for quality of life and disability are
presented for every condition and for the number of conditions in
Table 2. Depression, anxiety and stroke are the conditions with
the highest impact on quality of life and disability scores.
Hypertension is the condition with the lowest impact on quality
of life and disabitlity of the diseases assessed. The number of
chronic conditions is related to worse quality of life and disability.
Impact of single chronic conditions and multiple chronic
conditions on disability are presented in Tables 3 and 4.
Analogous information is given for quality of life in Tables 5
and 6. At a global level, the linear regression showed that,
individually, each chronic condition was related to poorer results
in quality of life and higher rates of disability, except for
hypertension, where no statistically significant difference was
found (Tables 3 and 5). In the regressions, higher educational level
and being married were also related with better outcomes in
quality of life and disability.
Co-occurring diabetes and cataracts were found to be associated
with higher disability (b: 9.76; 95% CI: 4.27, 15.25) and lower
quality of life (b: 24.01; 95% CI: 28.06, 0.05) (table 3 and
table 5).
Co-occurring asthma and COPD was associated with positive
quality of life (b: 5.17; 95%CI: 1.50, 8.85). Co-occurring
depression and anxiety showed lower disability but the result
was not statistically significant (b: 26.54; 95CI: 215.96, 2.89).
Suffering from several chronic conditions was associated with
higher disability, with scores in the questionnaire ranging from 3.6
(95% CI: 3.0, 4.1) to 38.2 (95% CI: 35.4, 40.9) when comparing
people with no diseases and people with 1 and 4+ conditions
respectively.
Similar changes were found with regard to the number of
conditions and quality of life, where the score fell from 76.5 (95%
CI: 75.6, 77.4) to 56.2 (95% CI: 53.5, 58.9). The regressions
showed a strong association between the number of chronic
conditions and both higher disability and worse quality of life
(Table 4 and Table 6).
Gender trends in quality of life and disability
As for diseases considered independently, women had poorer
results in disability scores compared with men with the same
conditions, except for asthma, depression and anxiety where no
difference was found (Table 2). Similar results were found in
quality of life although, in this case, stroke also showed no
difference across gender (Table 2). At an additive level, women
also had worse outcomes when considering a specific number of
chronic conditions, although having 4+ chronic conditions was
related to similar outcomes.
With regard to the regressions results, anxiety and angina were
only related to worse quality of life in women, while asthma and
edentulism were associated with worse results only in men
(table 5). For disability, separate regressions for men and women
also showed particular trends. Anxiety, cataract and diabetes were
only associated with poorer results for women while asthma was
associated with poorer results only in men (table 3). An increasing
positive association between the number of conditions and poor
results in disability and quality of life was found for both sexes
(table 4, table 6). Being single resulted in poorer results in quality
of life compared with being married only in men (table 5).
Discussion
This study has shown that there is a strong association between
chronic conditions and poor results in disability and quality of life,
both at individual and additive level. Our study also showed
relevant trends according to gender in this association.
Individual associations
The most remarkable result is that mental disorders (depression
and anxiety) have a higher impact on quality of life and disability
than most chronic physical conditions. Some studies have
suggested an intimate association between mental disorders and
changes in quality of life and disability in the elderly but they tend
to focus specifically on mental conditions or combinations of
mental disorders so that individual qualitative or quantitative
comparisons between different mental and physical chronic
diseases are not available [27,28,53–55]. Moreover, a high
proportion of studies to date did not include mental disorders
when analyzing chronic conditions [15,26,29,56]. There are few
studies available which include mental and physical conditions,
which show mixed results, so our results highlight the importance
of mental health in the elderly at this level [10,57–59]. Stroke is
the physical condition with the highest impact on quality of life,
followed by COPD, arthritis and angina. These conditions share
some similarities such as physical limitations or disabling
symptoms (pain, shortness of breath, etc.), having been previously
associated with poor health outcomes [26,60–65]. Asymptomatic
conditions such as diabetes or edentulism resulted in a lower
impact on quality of life. In this regard, our results complement the
results of previous studies that found a mixed effect of diabetes on
quality of life and disability but, in this study, we provide the
additional context of other chronic conditions [31,34,56,59,66–
68]. Hypertension turned out not to be associated with worse
outcomes while earlier studies have shown mixed results
[15,19,34,56,69–71]. When interpreting our results, it has to be
considered that the hypertension diagnosis was reported by the
respondents, so that a great proportion may have been receiving
medical care at the time of the interview. It has been shown that
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Table 1. Description of the sample of the Spanish Cohort of the COURAGE study.
TOTAL MALE FEMALE p value
Sample (n; %) 3625 (100%) 1643 (46.2%) 1982 (53.8%) -
Age (mean, SE) 66.45 (0.18) 65.77 (0.27) 67.05 (0.24) 0.001
Education (n; %) ,0.001
no education 1207 (32.6%) 499 (29.7%) 708 (35.0%)
primary 1075 (31.2%) 477 (30.2%) 598 (32.2%)
secondary 949 (25.5%) 449 (27.2%) 500 (24%)
university 393 (10.7%) 218 (12.9%) 175 (8.8%)
Household income (n; %) ,0.001
1st quintil 686 (22.0%) 304 (20.8%) 382 (23.1%)
2nd quintil 694 (21.7%) 254 (17.7%) 440 (28.2%)
3rd quintil 715 (21.6%) 311 (20.9%) 404 (25.6%)
4th quintil 745 (21.7%) 376 (25.0%) 369 (18.8%)
5th quintil 428 (13.0%) 229 (15.6%) 199 (10.7%)
Marital Status (n; %) ,0.001
single 310 (8.5%) 148 (9.0%) 162 (8.0%)
married 2258 (62.1%) 1262 (77.5%) 996 (48.9%)
divorced 266 (6.9%) 101 (5.4%) 165 (8.2%)
widow 791 (22.5%) 132 (8.1%) 659 (34.9%)
Urbanicity (n; %) 0.649
urban 3138 (83.8%) 1421 (84.3%) 1717 (83.4%)
rural 487 (16.2%) 222 (15.7%) 265 (16.6%)
Work (n; %) ,0.001
retired 1385 (41.3%) 884 (58.2%) 501 (26.9%)
other 1269 (35.7%) 241 (14.9%) 1028 (53.5%)
working 817 (23.0%) 435 (26.9%) 382 (19.6%)
QoL score (mean, SE) 71.02 (0.36) 73.35 (0.39) 69.02 (0.46) ,0.001
Disability score (mean, SE) 13.18 (0.52) 9.30 (0.50) 16.51 (0.74) ,0.001
Hypertension (n; %) 1331 (37.3%) 568 (35.6%) 763 (38.9%) 0.051
Diabetes (n; %) 514 (14.0%) 255 (15.1%) 259 (13.1%) 0.078
Angina (n; %) 236 (6.6%) 128 (7.8%) 108 (5.7%) 0.047
Asthma (n; %) 231 (6.3%) 90 (5.4%) 141 (7.1%) 0.064
Arthritis (n; %) 982 (26.8%) 266 (15.8%) 716 (36.3%) ,0.001
COPD (n; %) 233 (6.7%) 124 (8.3%) 109 (5.4%) 0.002
Stroke (n; %) 132 (4.6%) 62 (5.0%) 70 (4.3%) 0.428
Depression (n; %) 434 (12.1%) 117 (6.7%) 317 (16.7%) ,0.001
Anxiety (n; %) 55 (1.4%) 13 (0.6%) 42 (2.0%) ,0.001
Cataracts (n; %) 215 (6.0%) 62 (4.6%) 153 (7.2%) ,0.001
Edentulism (n; %) 677 (18.8%) 295 (17.3%) 382 (20.2%) 0.052
Asthma_COPD (n; %) 103 (2.9%) 55 (3.3%) 48 (2.5%) 0.205
Depression_anxiety (n; %) 42 (1.1%) 9 (0.4%) 33 (1.6%) ,0.001
Caratact_diabetes (n; %) 65 (1.7%) 21 (1.3%) 44 (2.0%) 0.060
Num chronic conditions (n; %) ,0.001
0 1173 (32.1%) 594 (36.4%) 579 (28.3%)
1 1074 (29.6%) 531 (31.3%) 543 (28.2%)
2 688 (18.5%) 275 (16.3%) 413 (20.4%)
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symptoms are responsible for the greatest impact on quality of life
in patients with hypertension so that patient monitoring and
treatment would minimize the few symptoms present in the
participants with hypertension [72]. Efforts to improve quality of
life and disability should focus on prioritizing mental disorders and
physical symptomatic conditions.
Pair combinations
With regard to co-occurring pairs of conditions, suffering from
diabetes and cataracts resulted in a synergic effect on disability and
quality of life. These results must be treated with caution.
Prevalence of cataracts is known to be strongly related to the
duration of diabetes and parameters reflecting poor diabetes
management, such as high levels of HbA1c, fasting blood sugar or
macroalbuminuria [73,74]. This poor control of diabetes, which
could also be related to other metabolic syndrome complications,
would lead the individual to a poorer health status and higher
degree of disability compared with the expected addition of the
individual effects of diabetes and cataracts.
Co-occurrence of asthma and COPD resulted in contrary
directionality of the results compared with the individual effect of
the diseases on quality of life. It does not alter the individual
negative effect of asthma and COPD on quality of life but suggests
a ceiling effect when having them simultaneously. Both asthma
and COPD are highly prevalent conditions in the elderly and this
has been defined as the asthma-COPD overlap syndrome, which
describes a frequency of overlapping diagnoses over 50% in
COPD patients aged over 80 years [75]. As the name suggests, this
situation involves features of both conditions and has recently been
related to poorer quality of life than that found in asthma cases
and similar to that of COPD [76]. In our case, 43% of the
participants diagnosed with COPD also suffered from asthma,
which supports the results seen in clinical settings. Some clinical
outcomes, which may differ from the individual conditions, could
be related to these results. For example, Fu et al. (2013) found, in a
longitudinal study, that patients with asthma-COPD overlap had a
better prognosis than COPD or asthma patients, although other
studies have showed more severe exacerbations when these
conditions co-occur [77,78]. Further research is needed to describe
the asthma-COPD overlap and its impact on quality of life.
Co-occurring depression and anxiety resulted in lower effects on
disability than theoretically expected although these results were
not statistically significant. Further study is needed to clarify the
combined impact of mental disorders in quality of life and
disability due to the close relationship between these disorders.
Additive impact of chronic conditions
At an additive level, there is a sharp and continuous decrease in
quality of life when suffering from more chronic conditions, with
Beta ranging from 23.26 (95% CI: 24.66, 21.93) in the group of
respondents with one chronic disease to218.10 (95% CI:220.95,
215.25) in the group with four and more conditions, which
underlines the relevance of multimorbidity in this outcome.
Similar results are found when assessing the association between
multimorbidity and disability with Beta results ranging from 3.57
(95% CI: 2.56, 4.56) in respondents with one condition up to
27.64 (95% CI: 24.99, 30.29) in patients with four and more
conditions. These results expand and complement the evidence
since most studies have focused on the impact of individual
conditions, specific pairs of conditions or organ domain classifi-
cations. [10,15,22,28,29,34,53,55,57,69,70,79,80]. Our results
support the descriptive analysis made by Lawson et al. (2013) in
which participants reporting longstanding conditions presented
reductions in preference-weighted health-related quality of life.
Their results, however, are not completely comparable since they
counted up to three chronic diseases, considered different
conditions and the count itself only allowed one condition for
every organ-based classification group [81]. Brettschneider et al.
(2013) and Heyworth et al. (2009) found that overall quality of life
and its dimensions, measured with the EQ-5D, decreased with an
increasing number of chronic diseases [59,82). However, the study
by Brettschneider et al. (2013) considered multimorbidity as a
continuous variable without assessing the impact of the specific
disease count, while Heyworth et al. (2009) only took six
conditions into account, excluding mental health, so that results
are complementary rather than comparable. On the other hand,
Tan et al. (2013) also found poorer results in quality of life with a
higher number of chronic conditions. However, there seemed to
be a ceiling effect between two and three chronic conditions while,
in our results, the group with four or more conditions shows a
noticeably lower quality of life compared with respondents with
three chronic conditions [71]. Our results in quality of life should
help to target multimorbidity patients as population subgroups in
which clinical, community and patient-centered care should be
prioritized to ensure the best possible quality of life [83]. With
regard to disability, little effort has previously been made in
considering the additive effect of chronic conditions, as stated
above. Our results suggest that multimorbidity patients require
special attention due to the association between the number of
chronic conditions and disability rates. Since disability per se
predicts future disability status and is related to poor health
outcomes, it is important to identify high-risk groups to develop
preventive, curative or palliative strategies [34]. For example,
patients at risk can benefit from interventions, such as resistance
strength training or preventive home visitation programs [84].
Gender trends
It is known that systematic gender-dependent errors can be
made when analyzing the results of a study due to androcentrism
or gender insensitivity [85]. Previous research on these topics has
Table 1. Cont.
TOTAL MALE FEMALE p value
3 372 (10.7%) 133 (9.1%) 239 (12.1%)
4+ 318 (9.1%) 110 (6.8%) 208 (11.0%)
Unweighted frequencies, and weighted means and proportions are displayed. Chi-square test for 2xN tables and T-test were performed to compare across gender.
NOTE: Household income was divided into 5 quintiles (the first indicating the lowest income). Education category ‘no education’ included those people that had never
been to school or did not finish primary school. Marital status ‘married’ category included currently married or cohabiting. Employment ‘other’ category included
training, homemakers, unemployed, voluntary work, health problems, caring for family, sick leave, no need to work, temporary time off and voluntary work. Anxiety
included Generalized Anxiety Disorder and Panic Disorder. Abbreviations: SE, standard error.
doi:10.1371/journal.pone.0111498.t001
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highlighted the specific need to address disparities and differences
in risk and interventions across gender groups of people with
chronic conditions [83]. Studies tend to consider gender when
adjusting the regression models but only some of them provide
descriptive results or separate analyses by gender, which in turn
are usually focused on specific conditions [10,29,33,63,68,86–88].
Consequently, our results covered the global sample as well as
those for males and females.
Our results have shown that women had higher risk of disability
than men after adjusting for covariates (b: 2.92; 95% CI: 1.72,
4.12) although the clinical relevance of this result is unclear since
there are no clinical cut-offs for these types of screening tools
Table 3. Impact of chronic conditions on disability.
Disability global Disability male Disability female
B (95% CI) p value B (95% CI) p value B (95% CI) p value
Intercept 211.75 (217.76,25.74) ,0.001 25.18 (211.34,0.97) 0.098 214.68 (222.30,27.05) ,0.001
Sex (ref. male) 2.92 (1.72,4.12) ,0.001 - - - -
Age (per each additional year) 0.32 (0.24,0.41) ,0.001 0.22 (0.12,0.31) ,0.001 0.42 (0.31,0.53) ,0.001
Marital status (ref: married)
divorced/separated 20.55 (22.70,1.59) 0.609 1.46 (20.82,3.76) 0.207 21.50 (24.23,2.23) 0.28
widow 2.15 (0.60,3.70) 0.007 1.66 (20.94,4.26) 0.208 1.36 (20.69,3.41) 0.192
single 0.61 (21.11,2.33) 0.486 20.13 (21.91,1.65) 0.886 0.83 (22.14,3.81) 0.582
Education level (ref: no studies)
primary 23.89 (25.46/22.320) ,0.001 23.85 (25.64,22.06) ,0.001 23.81 (26.24,21.38) 0.002
secondary 24.62 (26.23,23.02) ,0.001 25.15 (27.05,23.25) ,0.001 24.09 (26.17,22.00) ,0.001
university 25.80 (27.99,23.62) ,0.001 24.92 (26.69,23.16) ,0.001 26.78 (210.16,23.40) ,0.001
Urbanicity (ref: rural) 23.17 (25.07,21.27) 0.001 22.61 (25.04,20.19) 0.034 23.58 (26.13,21.03) 0.006
Chronic conditions
depression 15.70 (13.62,17.77) ,0.001 16.14 (12.10,20.17) ,0.001 15.60 (13.14,18.06) ,0.001
anxiety 11.17 (2.49,19.86) 0.012 11.40 (211.52,34.32) 0.327 11.94 (1.32,22.56) 0.028
angina 6.87 (4.52,9.22) ,0.001 6.01 (3.31,8.71) 0.034 7.62 (3.55,11.70) ,0.001
asthma 2.34 (0.28,4.40) 0.03 4.00 (0.17,7.83) 0.041 1.42 (21.35,4.20) 0.311
COPD 8.63 (6.21,11.05) ,0.001 9.12 (5.44,12.80) ,0.001 8.32 (4.84,11.80) ,0.001
cataract 3.28 (0.37,6.19) 0.027 0.08 (24.82,4.97) 0.975 4.60 (1.01,8.18) 0.012
arthritis 7.50 (5.95,9.06) ,0.001 7.41 (4.92,9.90) ,0.001 7.38 (5.42,9.34) ,0.001
diabetes 2.32 (0.56,4.08) 0.010 0.79 (20.95,2.53) 0.373 4.25 (1.57,6.94) 0.002
hypertension 0.14 (20.97,1.25) 0.802 20.37 (21.60,0.86) 0.554 0.170 (21.65,1.99) 0.854
edentulism 2.93 (1.19,4.68) 0.001 3.08 (1.00,5.16) 0.004 2.79 (0.03,5.54) 0.048
stroke 12.15 (8.08,16.22) ,0.001 15.90 (9.66,22.14) ,0.001 9.17 (4.13,14.21) ,0.001
Interactions
depression-anxiety 26.54 (215.96,2.89) 0.172 22.59 (228.70,23.52) 0.845 28.04 (219.52,3.43) 0.168
caratact-diabetes 9.76 (4.27,15.25) 0.001 15.41 (5.99,24.84) 0.002 6.28 (20.59,13.15) 0.073
Linear regression model for the global sample was adjusted for sex, age, marital status, education level, urbanicity, individual chronic conditions and interactions.
Analogous linear regressions were performed for male and female, adjusted by the same variables but sex. Results with 95% Confidence interval.
doi:10.1371/journal.pone.0111498.t003
Table 4. Impact of multiple chronic conditions on disability.
Number of chronic conditions (ref: not having a
condition) Disability global Disability male Disability female
B (95% CI) p value B (95% CI) p value B (95% CI) p value
1 3.57 (2.56,4.56) ,0.001 2.80 (1.66,4.85) ,0.001 4.40 (2.67,6.13) ,0.001
2 8.59 (6.92,10.27) ,0.001 7.32 (5.14,9.49) ,0.001 9.90 (7.54,12.26) ,0.001
3 14.61 (12.54,16.69) ,0.001 13.40 (10.06,16.74) ,0.001 15.59 (12.69,18.48) ,0.001
4+ 27.64 (24.99,30.29) ,0.001 27.11 (2.38,22.40) ,0.001 28.23 (24.82,31.63) ,0.001
Linear regression model for the global sample was adjusted for sex, age, marital status, education level, urbanicity and number of chronic conditions. Analogous linear
regressions were performed for male and female, adjusted by the same variables but sex. Results with 95% Confidence interval.
doi:10.1371/journal.pone.0111498.t004
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(effect size resulted in moderate-small values). This result is
comparable with the effect of diseases, such as diabetes (b: 2.32;
95% CI: 0.56, 4.08), but very low compared with depression (b:
15.70; 95% CI: 13.62, 217.77) or stroke (b: 12.15; 95% CI: 8.08,
216.22). Analogous results were found for quality of life.
Our results show higher disability and lower quality of life
average scores in women than in men for most chronic conditions
(e.g. women with angina had considerably higher scores for
disability and lower for quality of life compared with men). These
results reinforce the general idea that greater attention should be
paid to women to prevent and manage poor outcomes in disability
Table 5. Impact of chronic conditions on quality of life.
QoL global QoL male QoL female
B (95% CI) p value B (95% CI) p value B (95% CI) p value
Intercept 72.80 (69.41,76.19) ,0.001 72.89 (67.89,77.88) ,0.001 73,79 (68.65,78.93) ,0.001
Sex (ref. male) 20.91 (21.81,20.01) 0.048 - - - -
Age (per each additional year) 0.04 (20.02,0.09) 0.166 0.05 (20.02,0.11) 0.197 20.01 (20.08,0.07) 0,918
Marital status (ref: married)
divorced,separated 26.63 (28.48,24.77) ,0.001 28.82 (211.98,25.67) ,0.001 25.07 (27.37,22.76) ,0.001
widow 22.73 (24.05,21.42) ,0.001 23.39 (25.62,21.15) 0.003 21.71 (23.30,20.12) 0.035
single 23.47 (25.43,21.52) 0.001 25.55 (28.15,22.95) ,0.001 20.83 (23.70,2.03) 0.566
Education level (ref: no studies)
primary 2.76 (1.40,4.12) ,0.001 2.43 (0.55,4.30) 0.011 2.93 (1.16,4.70) 0.001
secondary 5.08 (3.32,6.82) ,0.001 4.48 (2.44,6.52) ,0.001 5.36 (3.01,7.72) ,0.001
university 7.75 (6.02,9.47) ,0.001 6.51 (4.27,8.75) ,0.001 8.34 (5.87,10.85) ,0.001
Urbanicity (ref: rural) 20.96 (22.70,0.79) 0.279 20.78 (22.77,1.22) 0.443 21.49 (23.65,0.673) 0.176
Chronic conditions
depression 214.00 (215.85,212.14) ,0.001 217.00 (219.98,214.03) ,0.001 212.79 (215.15,210.44) ,0.001
anxiety 27.82 (211.57,24.08) ,0.001 23.60 (29.40,22.19) 0.221 29.29 (213.77,24.80) ,0.001
angina 23.45 (25.20,21.69) ,0.001 22.30 (24.71,0.10) 0.060 24.67 (27.55,21.78) 0.002
asthma 23.40 (25.49,21.32) 0.002 24.66 (27.05,22.26) ,0.001 22.57 (25.40,0.26) 0.075
COPD 26.19 (28.39,24.00) ,0.001 25.33 (28.61,22.05) 0.002 27.00 (210.51,23.49) ,0.001
cataract 22.49 (24.61,20.37) 0.022 22.58 (25.56,0.40) 0.089 22.35 (25.08,0.38) 0.091
arthritis 23.52 (24.65,22.38) ,0.001 23.52 (25.31,21.73) ,0.001 23.45 (24.83,22.07) ,0.001
diabetes 21.49 (22.87,20.11) 0.035 21.60 (23.29,0.10) 0.065 21.21 (23.24,0.82) 0.241
hypertension 0.38 (20.50,1.26) 0.397 0.538 (20.69,1.77) 0.389 0.45 (20.88,1.77) 0.505
edentulism 21.63 (23.01,20.26) 0.020 22–21 (23.85,20.58) 0.008 21.08 (23.23,1.07) 0.322
stroke 28.16 (211.77,24.55) ,0.001 27.93 (211.47,24.38) ,0.001 28.88 (215.34,22.42) 0.007
Interactions
asthma-COPD 5.17 (1.50,8.85) 0.006 5.44 (0.41,10.48) 0.034 5.80 (20.74,12.33) 0.082
caratact-diabetes 24.01 (28.06,0.05) 0.053 24.64 (213.10,3.83) 0.281 23.87 (28.71,0.97) 0.116
Linear regression model for the global sample was adjusted for sex, age, marital status, education level, urbanicity, individual chronic conditions and interactions.
Analogous linear regressions were performed for male and female, adjusted by the same variables but sex. Results with 95% Confidence interval.
doi:10.1371/journal.pone.0111498.t005
Table 6. Impact of multiple chronic conditions on quality of life.
Number of chronic conditions (ref: not having a
condition) QoL global QoL male QoL female
B (95% CI) p value B (95% CI) p value B (95% CI) p value
1 23.29 (24.66,21.93) ,0.001 21.98 (23.37,20.60) 0.005 24.68 (26.73,22.62) ,0.001
2 25.15 (26.62,23.69) ,0.001 23.89 (25.74,22.04) ,0.001 26.15 (28.15,24.14) ,0.001
3 210.67 (212.34,29.00) ,0.001 211.01 (213.42,28.60) ,0.001 210.70 (212.93,28.48) ,0.001
4+ 218.10 (220.95,215.25) ,0.001 216.85 (219.93,213.77) ,0.001 219.04 (223.19,214.88) ,0.001
Linear regression model for the global sample was adjusted for sex, age, marital status, education level, urbanicity and number of chronic conditions. Analogous linear
regressions were performed for male and female, adjusted by the same variables but sex. NOTE: QoL = quality of life. Results with 95% Confidence interval.
doi:10.1371/journal.pone.0111498.t006
Impact of Multimorbidity on Disability and Quality of Life in Spain
PLOS ONE | www.plosone.org 9 November 2014 | Volume 9 | Issue 11 | e111498
and quality of life. Additionally, it specifically clarifies this topic
with regard to chronic conditions [68,89–91]. However, similar
quality of life and disability scores were found in both sexes for
depression, anxiety, asthma and stroke (only for quality of life in
stroke). When comparing the global scores across gender, a greater
impact is seen in women but this difference disappears with respect
to quality of life when three or more conditions are present. The
impact of the increasing number of chronic conditions would
appear to be similar across gender when people reach a certain
level of multimorbidity.
When assessing the regression models for males and females,
most conditions showed similar behavior as the reported in the
regression including all participants. For some conditions,
however, this association disappeared in men or women. Anxiety
and angina were statistically related to poorer results in women
only, while asthma and edentulism were related to poorer results
solely in men. Since anxiety prevalence in men was relatively low,
we think this result may be biased by the power of the study.
Analogously, anxiety, cataracts and diabetes were associated with
higher rates of disability solely in women while asthma was found to
be related to higher disability in men. With regard to the number of
chronic conditions, a greater impact on quality of life and disability
was found in both genders. These results suggest that the effect of
conditions in each gender group may differ and should be
considered in future studies. With regard to asthma, for example,
the management of the disease in men should focus particularly on
preventing loss of quality of life and physical functioning.
Strengths and limitations
Our study’s main strength is that results are extrapolated to the
entire Spanish older adult population. In the future, comparison
will be possible with other countries included in the COURAGE
and SAGE studies. It is also remarkable that the selection of
chronic diseases, including depression and anxiety, were mainly
omitted in previous studies despite having been related to poor
health outcomes at an individual level. Diagnosis by means of both
self-report plus symptom algorithms also allows a more complete
picture of the participants to emerge compared with other studies.
There are, however, limitations in our study. Its cross-sectional
nature identifies associations but does not allow conclusions on
cause-and-effect relationships to be drawn. Moreover, age effects
may not be distinguished from cohort effects. Longitudinal studies
are needed to better establish the association between multi-
morbidity, quality of life and disability, thus reducing this bias.
Multimorbidity studies would benefit from a standardized
definition and disease inclusion criteria [50]. For example, the
exhaustive ‘‘Expanded Diagnosis Clusters of the ACG’’ system
have been used in some studies, although it becomes complex to
employ outside the clinical setting and in the case of poor
integration of health care levels [92]. The choice of chronic
conditions is also relevant since it is known that a higher number
of assessed conditions results in a higher proportion of multi-
morbidity [5]. Our selection of chronic conditions was made
according to the SAGE study, focusing on a limited number of
highly prevalent conditions that are a major cause of disability,
through a method that can be applied across countries. There is,
however, a need to include diagnoses of other common conditions
known to have a considerable impact on quality of life, disability
and health care resources, in future studies. Research on
multimorbidity, as highlighted by the recent review by Prados-
Torres et et al. (2012), may include diseases such as malignancies,
congestive heart failure or anemia [92].Moreover, when assessing
specific pairs, we chose those highly prevalent pairs of conditions
with a high degree of interaction shown in the multimorbidity
index. However, further studies including other combinations are
required to deepen knowledge of less common co-occurring
conditions. The self-reported data-collection method could also
bias the results, but this effect may be minimized as a good
correlation between medical records and self-reported diagnosis
has been found [93,94]. Our analysis does not allow consideration
of the progression and severity of conditions, which would be
advisable in future studies. For example, severe COPD cases or
poor glycemic control in diabetes may be related to poorer health
outcomes [95]. There is a possibility that some respondents who
did not take the medication prescribed by their doctors answered
that they were not receiving treatment and were incorrectly
classified as ‘‘not suffering from a specific disease’’. This limitation
is minimized since the question was quite open ‘‘did you received
treatment’’, rather than asking whether they were ‘‘taking the
medication’’ and also due to the inclusion of the symptoms
algorithm in most conditions. With regard to the analyses including
the number of chronic conditions, further study is needed to clarify
if greater contribution to the results is due to some conditions rather
than others. We considered theoretical similar impact in our
analyses to be consistent with the previous literature on that regard.
Another limitation when analyzing the results is the geopolitical
context. Specific results for an individual condition may vary
according to external factors that should be analyzed if detected
[96,97]. Although financial crises may impact some results, such as
the prevalence of mental disorders, recent evidence suggests that
health in Spain has continued to improve during the first four years
of the current economic recession, so it seems this bias would be
reduced [98,99]. Finally, separate results for women and men
(average scores and regression models) obtained in our article have
shed some light on gender issues but further efforts focusing on
differences across gender would be needed in future studies.
Conclusion
The results of this study contribute to a deeper understanding of
the effect of chronic conditions on quality of life and disability. In
Spain, multimorbidity is a prevalent phenomenon among elderly
people in the community that increasingly affects both disability
and quality of life as more co-occurring conditions accumulate.
Multimorbidity patients should be considered as targets for
clinical, community and patient-centered care based on preven-
tive, curative or palliative strategies. Our results are especially
relevant since little effort has been previously made to consider the
additive effect of common chronic conditions on quality of life and
disability. At an individual level, efforts to improve quality of life
and disability should prioritize prevention and management of
mental disorders and physical symptomatic conditions since they
are associated with poorer outcomes than mainly asymptomatic
conditions such as hypertension. Our results also highlight the need
to include mental disorders, selected in very few previous studies,
when analyzing multimorbidity because of their great impact on the
results. Finally, there is need to consider gender as an important
factor when assessing multimorbidity and designing interventions
for multimorbidity patients since specific trends arise in some
outcomes with women showing worse health results in most cases.
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